8 October 2018 - - US-based diagnostic and therapeutic technologies company Qualigen, Inc has been issued China Patent Number ZL 2017 3 0590489.7, which covers the design of Qualigen's novel FastPack 2.0 Reagent Pouch, the company said.

The patent, which provides protection until November 2027, is part of a family of patents and patent applications that protect Qualigen's FastPack "Laboratory in a Pouch" rapid immunoassay diagnostic technology.

"We are pleased to strengthen our intellectual property protection with the addition of this patent in China covering our core FastPack diagnostic technology," said Michael S. Poirier, chief executive officer of Qualigen. "We have consistently sought to protect, expand, and improve uses of our FastPack diagnostic technologies in the US and worldwide. As such, we now have over 40 issued patents in this space."

Qualigen is focused on the development, production and commercialisation of innovative medical technologies, including its flagship FastPack point-of-care immunoassay system and novel therapeutic technologies for treatment of cancers and infectious diseases.